Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

P3 Health Partners Inc. - Class A Common Stock (NQ: PIII )

0.2300 -0.0090 (-3.77%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about P3 Health Partners Inc. - Class A Common Stock

< Previous 1 2 3 4 5 Next >
P3 Health Partners Inc. (“P3”) had Impressive 2022 Year-End Results with Capitated Revenue of approximately $1 Billion Dollars; a Healthcare Management Company Focused on Helping Both Patients and Providers (NASDAQ: PIII)
Via Viz Release
P3 Health Partners Announces Fourth Quarter and Full-Year 2022 Results
From P3 Health Partners Inc.
Via Business Wire
P3 Health Partners Inc. Announces Approximately $90 Million Private Placement
From P3 Health Partners Inc.
Via Business Wire
Carlyle Group, Nikola And 3 Stocks To Watch Heading Into Friday
With US futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 479 stocks made new 52-week lows. 
Via Benzinga
Analyst Seems Optimistic On P3 Health Partners Despite Mixed Interim Annual Results
Via Benzinga
US Stocks Rise For Second-Straight Session, Investor Fear Eases
The CNN Money Fear and Greed index showed further easing in the fear level among U.S. investors. US stocks closed higher for a second straight session on Thursday, with the Dow Jones adding more than... 
Via Benzinga
P3 Health Partners Announces Date Change for Fourth-Quarter and Full-Year 2022 Earnings Call
From P3 Health Partners Inc.
Via Business Wire
Earnings Scheduled For March 30, 2023
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday! 
Via InvestorPlace
P3 Health Partners to Report Fourth-Quarter and Full-Year 2022 Financial Results on March 30
From P3 Health Partners Inc.
Via Business Wire
P3 Health Partners Affirms 2023 Outlook and Schedules Earnings Call for 2022 Results
From P3 Health Partners Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
  Tuesday's morning session saw 84 companies set new 52-week lows. 
Via Benzinga
P3 Health Partners Executive to Present at Upcoming Investor Conferences
From P3 Health Partners Inc.
Via Business Wire
P3 Health Partners CEO to Present at Upcoming Investor Conference
From P3 Health Partners Inc.
Via Business Wire
Billion Dollar Healthcare Giant P3 Health Partners Inc. (NASDAQ: PIII) Focused on Helping Both Patients and Providers Affirms Revenue Guidance of 1.2 Billion Plus for 2023; a 65% Increase over 2021
Via Get News
Billion Dollar Healthcare Giant P3 Health Partners Inc. (NASDAQ: PIII) Focused on Helping Both Patients and Providers Affirms Revenue Guidance of 1.2 Billion Plus for 2023; a 65% Increase over 2021
Via Viz Release
Stocks That Hit 52-Week Lows On Friday
  During Friday, 48 stocks hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 22 companies hit new 52-week lows. 
Via Benzinga
P3 Health Partners Reaffirms Guidance For 2022 and Announces Guidance For 2023
From P3 Health Partners Inc.
Via Business Wire
P3 Health Partners to Present at the 41st Annual J.P. Morgan Healthcare Conference
From P3 Health Partners Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
  Thursday's session saw 329 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 298 companies achieved new lows for the year. 
Via Benzinga
P3 Health Partners Names Atul Kavthekar Chief Financial Officer
From P3 Health Partners Inc.
Via Business Wire
P3 Health Partners Provides Third-Quarter and Year-to-Date 2022 Financial Results
From P3 Health Partners, Inc.
Via Business Wire
P3 Health Partners to Present Third Quarter 2022 Financial Results
From P3 Health Partners Inc.
Via Business Wire
P3 Health Partners Announces Participation in Credit Suisse Healthcare Conference
From P3 Health Partners Inc.
Via Business Wire
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. 
Via Benzinga
P3 Health Partners Announces Nasdaq’s Confirmation that it has Regained Compliance with Listing Requirements
From P3 Health Partners Inc.
Via Business Wire
P3 Health Partners Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
From P3 Health Partners Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.